France is the biggest consumer of medicine in Europe, and every year 500 new drugs are poured into the French market. But before they make their way into our medicine cabinet, they have all been tested by human guinea pigs who loan their body to science. Today, half the clinical trials done by Western countries are being conducted in emerging markets. For the last five years, Argentina, with a population of 41 million, has become the favorite destination for the big pharmaceutical companies. In Santiago del Estero, one of the poorest rural provinces of Argentina, the British lab GSK has tested on thousands of babies the drug Synflorix—a new vaccine against meningitis, otitis, and pneumonia.